查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985974

美国乳房切片设备市场：市场规模、份额和趋势分析（按产品类型、手术类型、引导技术、最终用途和地区划分），细分市场预测（2026-2033 年）

U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type, By Procedure Type, By Guidance Technology, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国乳房切片设备市场概述

据估计，2025 年美国乳房切片设备市场价值为 11.8 亿美元，预计到 2033 年将达到 16 亿美元，2026 年至 2033 年的复合年增长率为 3.9%。

乳癌发生率的上升以及由此导致的对早期发现和准确诊断的重视，推动了市场成长，进而增加了筛检和诊断过程中所需的切片检查次数。

患者和临床医生对该设备的高度认知，加上系统性的筛检计画和有利的保险报销政策，进一步推动了该设备的普及。此外，微创穿刺粗针切片、真空辅助系统、与先进影像技术（超音波、磁振造影、3D乳房X光摄影等）的整合以及人工智慧驱动的诊断工作流程等技术进步，正在拓展该设备的临床效用，提高手术精准度和患者舒适度，并促进更广泛的临床应用。

美国乳癌发生率的上升直接推动了乳房切片设备市场的成长。这是因为不断增加的新发和疑似癌症病例促使人们对活检进行诊断以确诊。在美国，乳癌是女性最常见的癌症，每年报告的新增侵袭性和非侵袭性病例达数十万例。这导致常规筛检和影像检查检查发现异常时进行的后续切片检查数量增加。随着发病率的上升和筛检项目的扩大，医疗专业人员进行更多切片检查以确诊、制定治疗方案并排除恶性肿瘤，从而导致空芯针穿刺活检、真空辅助切片检查和影像引导乳房切片设备的使用量增加。

随着乳房X光检查和磁振造影（MRI）等筛检计画的推广，越来越多的可疑病变被发现，因此需要透过空芯针穿刺活检和真空辅助切片检查进行组织取样。诊断数量的持续增长推动了医院和门诊对先进影像导引切片检查系统的需求。近期行业趋势表明，病例检出率的提高与设备创新之间存在着密切的关联。例如，2026年2月，丹纳赫公司（Danaher Corporation）旗下子公司Mammotome发布了Mammotome Prima MR双真空辅助乳房活检系统，这是首个设计用于在MRI扫描室切片检查过程中放置于患者身旁的系统。这些创新透过提升医护人员在MRI引导手术中的协作效率和工作流程效率，有效缓解了乳癌发病率上升带来的日益繁重的手术负担，从而加速了美国乳房切片设备产业的技术应用和整体市场成长。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：美国乳房切片设备市场：影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 美国乳房切片设备市场：分析工具
    • 波特五力分析
    • PESTEL 分析

第四章：美国乳房切片设备市场：按产品分類的估算与趋势分析

  • 美国乳房切片设备市场：按产品分類的波动分析（2025-2033 年）
  • 美国乳房切片器材市场：市场规模与趋势分析：按产品分类（2021-2033 年）
    • 切片检查引导系统
    • 切片检查驱动器/牙科手机
    • 切片检查台
    • 切片检查耗材
    • 其他消耗品

第五章：美国乳房切片设备市场：依手术类型分類的估算与趋势分析

  • 美国乳房切片器械市场：按手术类型分類的波动分析（2025-2033 年）
  • 美国乳房切片器械市场：市场规模和趋势分析：按手术类型划分（2021-2033 年）
    • 真空辅助切片检查（VAB）
    • 核心针穿刺切片（CNB）
    • 细针穿刺切片检查（FNAB）
    • 手术（开放式）切片检查
    • 液态生物检体

第六章：美国乳房切片设备市场：领先技术的估算与趋势分析

  • 美国乳房切片设备市场：依感应技术分類的波动分析（2025-2033 年）
  • 美国乳房切片设备市场：市场规模与趋势分析：按领先技术划分（2021-2033 年）
    • 在超音波引导下
    • 乳房X光摄影/立体定向
    • 磁共振引导

第七章：美国乳房切片设备市场：依最终用途分類的估算与趋势分析

  • 美国乳房切片设备市场：按最终用途分類的波动分析（2025-2033 年）
  • 美国乳房切片设备市场：市场规模和趋势分析：按最终用途划分（2021-2033 年）
    • 医院
    • 门诊手术中心（ASC）
    • 乳房护理专科中心
    • 诊断中心/影像诊断中心

第八章 竞争情势

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司分类
  • 企业市场占有率分析（2025 年）
  • 企业热力图分析
  • 策略规划
    • 业务拓展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 研究与开发
    • 公司简介
    • Hologic, Inc.
    • Mammotome (Danaher)
    • BD
    • Argon Medical
    • Merit Medical Systems
    • GE HealthCare
    • Cook Medical
    • MOLLI Surgical (Stryker)
    • Planmed Oy
    • Siemens Healthineers
    • Fujifilm Healthcare
    • INRAD
    • Resitu Medical
    • TransMed7, LLC.
Product Code: GVR-4-68040-865-5

U.S. Breast Biopsy Devices Market Summary

The U.S. breast biopsy devices market size was estimated at USD 1.18 billion in 2025 and is anticipated to reach USD 1.60 billion by 2033, growing at a CAGR of 3.9% from 2026 to 2033. The market growth driven by the rising incidence of breast cancer and the consequent emphasis on early detection and accurate diagnosis, which increases the volume of biopsy procedures required in screening and diagnostic pathways.

High awareness among patients and clinicians, supported by structured screening programs and favorable reimbursement landscapes, further propels device adoption. In addition, technological advancements, including minimally invasive core-needle and vacuum-assisted systems, integration with advanced imaging modalities (e.g., ultrasound, MRI, 3D mammography), and AI-enhanced diagnostic workflows, are expanding clinical utility, improving procedural accuracy and patient comfort, and encouraging broader clinical integration.

The rising prevalence of breast cancer in the U.S. directly drives growth in the breast biopsy devices market because a higher number of new and suspected cancer cases increases the demand for diagnostic confirmation through tissue sampling. In the U.S., breast cancer is the most commonly diagnosed cancer among women, with hundreds of thousands of new invasive and non-invasive cases reported annually, prompting more routine screening and follow-up biopsies when abnormalities are detected on imaging. As incidence rates climb and screening programs expand, healthcare providers perform more biopsies to confirm diagnoses, guide treatment decisions, and rule out malignancy, thereby boosting utilization of core-needle, vacuum-assisted, and image-guided breast biopsy devices.

As screening programs such as mammography and MRI expand, more suspicious lesions are detected, necessitating tissue sampling via core-needle or vacuum-assisted biopsy. This sustained rise in diagnostic volumes increases demand for advanced, image-guided biopsy systems in hospitals and ambulatory centers. The link between higher case detection and device innovation is evident in recent industry developments, for instance, in February 2026, Mammotome, a part of Danaher Corporation, introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the first system designed to be positioned inside the MRI scanner room at the patient's side during biopsy. By improving clinician coordination and workflow efficiency in MRI-guided procedures, such innovations address the growing procedural burden driven by rising breast cancer prevalence, thereby accelerating technology adoption and overall market growth in the U.S. breast biopsy devices sector.

U.S. Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. breast biopsy devices market report based on product, procedure type, guidance technology, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopsy Guidance Systems
    • Biopsy Drivers & Handpieces
    • Vacuum-Assisted Biopsy (VAB) Drivers
  • Core Needle Biopsy (CNB) Guns
    • Automated
    • Semi-Automated
  • Biopsy Tables
    • Prone Tables
    • Upright/Add-on Tables
  • Biopsy Consumables
    • Needles & Probes
    • Site Markers & Clips
    • By Shape/Design
    • Standard Geometric Markers
    • Ring
    • Cross
    • Ribbon
    • Others
    • Advanced Anchoring Markers
    • Anchor
    • Wing, "U" Shape
    • Q" Shape
    • 3D / Expandable Markers
    • 3D Ribbon
    • 3D Sphere
    • 3D Mesh
    • Localization Systems
    • Traditional Wires
    • Wireless Seeds-RFID/Magnetic
  • Other Consumables
  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Vacuum-Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)
  • Surgical (Open) Biopsy
  • Liquid Biopsy
  • Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ultrasound-Guided
  • Mammography / Stereotactic-Guided
  • MRI-Guided
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Breast Care Centers
  • Diagnostic Centers/Imaging Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Procedure Type
    • 1.1.3. Guidance Technology
    • 1.1.4. End Use
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Biopsy Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing burden of breast cancer
      • 3.2.1.2. Expansion of breast cancer screening programs
      • 3.2.1.3. Technological advancements in imaging-guided biopsy
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced biopsy technologies
      • 3.2.2.2. Limited access to diagnostic facilities in low-resource settings
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of screening programs in emerging economies
      • 3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
      • 3.2.3.3. Integration with next-generation imaging and AI
      • 3.2.3.4. Expansion of outpatient and ambulatory care
      • 3.2.3.5. Rising demand for personalized and precision diagnostics
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Patient anxiety and procedure hesitation
      • 3.2.4.2. Limited skilled workforce
  • 3.3. U.S. Breast Biopsy Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. U.S. Breast Biopsy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Biopsy Guidance Systems
      • 4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biopsy Drivers & Handpieces
      • 4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
        • 4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Core needle biopsy (CNB) guns
        • 4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.2. Automated
          • 4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.3. Semi-automated
          • 4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biopsy tables
      • 4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Prone tables
        • 4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Upright/add-on tables
        • 4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biopsy consumables
      • 4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.2. Needles & probes
        • 4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3. Site markers & clips
        • 4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.2. By shape/design
          • 4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3. Standard geometric markers
          • 4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.2. Ring
            • 4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.3. Cross
            • 4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.4. Ribbon
            • 4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.5. Others
            • 4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4. Advanced anchoring markers
          • 4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.2. Anchor
            • 4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.3. Wing, "U" shape
            • 4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.4. "Q" shape
            • 4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5. 3D / expandable markers
          • 4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.2. 3D ribbon
            • 4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.3. 3D sphere
            • 4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.4. 3D Mesh
            • 4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4. Localization systems
        • 4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.2. Traditional wires
          • 4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.3. Wireless Seeds-RFID/magnetic
          • 4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Other Consumables
      • 4.3.5.1. Other consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Biopsy Devices Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Biopsy Devices Market: Procedure Type Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Procedure Type, 2021 to 2033 (USD Million)
    • 5.3.1. Vacuum-Assisted Biopsy (VAB)
      • 5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Core Needle Biopsy (CNB)
      • 5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Fine Needle Aspiration Biopsy (FNAB)
      • 5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Surgical (Open) Biopsy
      • 5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Liquid Biopsy
      • 5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
    • 6.3.1. Ultrasound-Guided
      • 6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Mammography / Stereotactic-Guided
      • 6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. MRI-Guided
      • 6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Ambulatory Surgical Centers (ASCs)
      • 7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Specialized Breast Care Centers
      • 7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Diagnostic Centers/Imaging Centers
      • 7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Hologic, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Mammotome (Danaher)
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. BD
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Argon Medical
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Merit Medical Systems
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. GE HealthCare
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Cook Medical
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. MOLLI Surgical (Stryker)
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Planmed Oy
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Siemens Healthineers
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Fujifilm Healthcare
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. INRAD
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Resitu Medical
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. TransMed7, LLC.
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. breast biopsy devices market, by product type 2021 - 2033 (USD Million)
  • Table 3 U.S. breast biopsy devices market, by procedure type 2021 - 2033 (USD Million)
  • Table 4 U.S. breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 5 U.S. breast biopsy devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. breast biopsy devices market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 U.S. breast biopsy devices - market size and growth prospects (USD Million)
  • Fig. 11 U.S. breast biopsy devices market: Industry Value Chain Analysis
  • Fig. 12 U.S. breast biopsy devices market: Market Dynamics
  • Fig. 13 U.S. breast biopsy devices market: PORTER's Analysis
  • Fig. 14 U.S. breast biopsy devices market: PESTEL Analysis
  • Fig. 15 U.S. breast biopsy devices market share by product type, 2025 & 2033 (USD Million)
  • Fig. 16 Breast biopsy devices market, by product type: market share, 2025 & 2033.
  • Fig. 17 Biopsy guidance systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Biopsy drivers & handpieces market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Semi-automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Biopsy tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Prone tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Upright/add-on tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Biopsy consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Needles & probes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Site markers & clips market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 By shape/design market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Standard geometric markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 31 Ring market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 32 Cross market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Advanced anchoring markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Anchor market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Wing, "U" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 "Q" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 3D / expandable markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 39 3D ribbon market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 40 3D sphere market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 41 3D mesh market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 42 Localization systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 43 Traditional wires market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 45 Other consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 U.S. breast biopsy devices market share by procedure type, 2025 & 2033 (USD Million)
  • Fig. 47 U.S. breast biopsy devices market, by procedure type: market share, 2025 & 2033.
  • Fig. 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 49 Core needle biopsy (CNB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 51 Surgical (open) biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 52 Liquid biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 53 U.S. breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
  • Fig. 54 U.S. breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
  • Fig. 55 Ultrasound-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 56 Mammography / stereotactic-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 57 MRI-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 58 U.S. breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 59 U.S. breast biopsy devices market, by end use: market share, 2025 & 2033.
  • Fig. 60 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 62 Specialized breast care centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 64 Key company categorization
  • Fig. 65 Company market positioning
  • Fig. 66 Key company market share analysis, 2025
  • Fig. 67 Strategic framework